FOXP3 and hepatocellular carcinoma: (95) has discovered that the Foxp3 promoter and CpG region are hypermethylated by NA (cytosine-5)-methyl transferase 1 (DNMT1), which can limit Foxp3+Treg function and negatively controls HCC progression.